Search Results - rafael+irizarry

2 Results Sort By:
Methylation Anti-Profiling a Novel Approach to Diagnosing Cancer
Novelty:The disclosed technology is a novel approach to diagnosing cancer, by looking for loss of methylation stability in gene expression instead of searching for specific methylation profiles.Value Proposition:The conventional approach to identifying epigenetic cancer markers is by querying the methylation profiles at specific sites within the DNA....
Published: 6/27/2024   |   Inventor(s): Andrew Feinberg, Rafael Irizarry
Keywords(s): Biomarker, Cancers, Clinical Diagnostics, Diagnostic Biomarker, Disease Indication, In Vitro Diagnostics
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > Diagnostic Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Diagnostics
Novel Screen for Hypermethylated Genes as Biomarkers to Diagnose/ Prognose Colorectal Cancer
C10533: Novel Screen for Hypermethylated Genes as Biomarkers to Diagnose/ Prognose Colorectal CancerValue Proposition: ADVANTAGES • Combination of array-design and computational algorithms makes the assay uniquely efficient for colon cancer diagnostics/prognostics for fast results and shorter time to patient treatment. • Technology requires...
Published: 6/27/2024   |   Inventor(s): Rafael Irizarry, Andrew Feinberg
Keywords(s): Biomarker, Cancers, Clinical Diagnostics, Colorectal Cancer, Disease Indication, Epigenetic, In Vitro Diagnostics, Prognostic Biomarker
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Gastroenterology, Clinical and Disease Specializations > Oncology > Colorectal Cancer, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Diagnostics > Prognostics Biomarkers, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Oncology
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum